Genetically modified non-human animal with human or chimeric genes
AssigneesBiocytogen Pharmaceuticals (Beijing) Co., Ltd., Biocytogen JiangSu Co., Ltd.
InventorsYuelei Shen, Meiling Zhang, Jiawei Yao, Chaoshe Guo, Yanan Guo, Yang Bai, Rui Huang, Lei Zhao, Chengzhang Shang
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) IL6R and/or IL6, and methods of use thereof.
Claims21
-90. (canceled)
A genetically-modified, non-human animal whose genome comprises at least one chromosome comprising a sequence encoding a human interleukin-6 receptor (IL6R), wherein the sequence further comprises a Woodchuck Hepatitis Virus (WHP) Posttranscriptional Regulatory Element (WPRE).
A genetically-modified, non-human animal whose genome comprises at least one chromosome comprising a sequence encoding a human IL6 at an endogenous IL6 gene locus.
A method of producing a genetically-modified rodent, the method comprising
- modifying a genome of an embryo of a rodent by CRISPR associate protein 9 (Cas9) with sgRNAs that target SEQ ID NO:
- 26 and SEQ ID NO:
- 34 and a targeting vector, thereby generating a genome in the embryo that comprises at least one chromosome comprising a sequence encoding a chimeric IL6, wherein the targeting vector comprises a 5′ homologous arm, a 3′ homologous arm, and a human IL6 gene fragment;
- and
- transplanting the embryo to a recipient rodent to produce a genetically-modified rodent.
Dependencies are inferred from the claim text.